StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.83+0.05 (+6.00%)

Close on Nov 18, 2026Market cap $9.82MP/E –Yield –

CytoMed Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was 324.39K SGD, up 366.7% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025324.39K SGD+366.7%
FY2024Dec 31, 202469.50K SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?